Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DOJ2A5
|
|||
| Drug Name |
VTX-801
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Wilson disease [ICD-11: 5C64.00] | Phase 2 | [1] | |
| Company |
Pfzer
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Copper-transporting ATPase 2 (ATP7B) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04537377) A Phase I/II, Multicenter, Non-randomized, Open Label, Adaptive Design, 5-year Follow-up, Single Dose-escalation Study of VTX-801 in Adult Patients With Wilson's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.